156x Filetype XLSX File size 0.05 MB Source: www.cms.gov
Sheet 1: Measure to Value Set Crosswalk
Measure Number | Measure Name | Value Set |
MI2.5 | Members with first follow-up visit within 30 days of hospital discharge | Ambulatory Visits |
MI2.5 | Members with first follow-up visit within 30 days of hospital discharge | Other Ambulatory Visits |
MI2.5 | Members with first follow-up visit within 30 days of hospital discharge | Inpatient Stay |
MI2.5 | Members with first follow-up visit within 30 days of hospital discharge | Nonacute Inpatient Stay |
MI2.5 | Members with first follow-up visit within 30 days of hospital discharge | Discharges due to Death |
MI2.6 | Members, regardless of age, discharged from an inpatient facility to home or any other site of care for whom a transition record was transmitted within 24 hours of discharge to the facility or primary care provider or other health care professional designated for follow-up care | Type of Bill #1 |
MI2.6 | Members, regardless of age, discharged from an inpatient facility to home or any other site of care for whom a transition record was transmitted within 24 hours of discharge to the facility or primary care provider or other health care professional designated for follow-up care | Discharge Status |
MI2.6 | Members, regardless of age, discharged from an inpatient facility to home or any other site of care for whom a transition record was transmitted within 24 hours of discharge to the facility or primary care provider or other health care professional designated for follow-up care | Type of Bill #2 |
MI2.6 | Members, regardless of age, discharged from an inpatient facility to home or any other site of care for whom a transition record was transmitted within 24 hours of discharge to the facility or primary care provider or other health care professional designated for follow-up care | Revenue Code |
MI2.6 | Members, regardless of age, discharged from an inpatient facility to home or any other site of care for whom a transition record was transmitted within 24 hours of discharge to the facility or primary care provider or other health care professional designated for follow-up care | Inpatient Facility Discharge Exclusions |
MI5.2 | Members using self-directed arrangements through a fiscal intermediary | Waiver Services |
MI5.2 | Members using self-directed arrangements through a fiscal intermediary | Chore Services |
MI5.2 | Members using self-directed arrangements through a fiscal intermediary | Environmental Modifications |
MI5.2 | Members using self-directed arrangements through a fiscal intermediary | Expanded Community Living Supports |
MI5.2 | Members using self-directed arrangements through a fiscal intermediary | Non-Medical Transportation |
MI5.2 | Members using self-directed arrangements through a fiscal intermediary | Preventive Nursing Services |
MI5.2 | Members using self-directed arrangements through a fiscal intermediary | Private Duty Nursing |
MI5.2 | Members using self-directed arrangements through a fiscal intermediary | Respite |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | Hospice |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH Stand Alone Acute Inpatient |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | Schizophrenia |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH Acute Inpatient |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH Acute Inpatient POS |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH Stand Alone Outpatient/PH/IOP |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH Outpatient/PH/IOP |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH Outpatient/PH/IOP POS |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | ED |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH ED |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | ED POS |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH Stand Alone Nonacute Inpatient |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH Nonacute Inpatient |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | BH Nonacute Inpatient POS |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | Dementia |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | Long-Acting Injections 14 Days Supply |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | Long-Acting Injections 28 Days Supply |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | Oral Antipsychotic Medications List |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | Long-Acting Injections 14 Days Supply Medications List |
MI5.3 | Adherence to antipsychotic medications for individuals with schizophrenia | Long-Acting Injections 28 Days Supply Medications List |
MI5.6 | Care for adults - medication review | Hospice |
MI5.6 | Care for adults - medication review | Medication Review |
MI5.6 | Care for adults - medication review | Medication List |
MI5.6 | Care for adults - medication review | Transitional Care Management Services |
MI7.1 | Emergency department visits for ambulatory care-sensitive conditions | ED |
MI7.3 | Annual Dental Visit | Hospice |
MI7.3 | Annual Dental Visit | Dental Visits |
Current Procedural Terminology (CPT)® is a registered trademark of the American Medical Association. CPT copyright 2014 American Medical Association. All rights reserved. |
no reviews yet
Please Login to review.